VICOM Ltd (SGX:WJP)
1.640
+0.010 (0.61%)
Aug 7, 2025, 5:04 PM SGT
CTI BioPharma Revenue
In the year 2024, VICOM had annual revenue of 119.48M SGD with 6.77% growth. VICOM had revenue of 63.18M in the half year ending December 31, 2024, with 14.93% growth.
Revenue
119.48M
Revenue Growth
+6.77%
P/S Ratio
4.84
Revenue / Employee
124.59K
Employees
959
Market Cap
577.95M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 119.48M | 7.58M | 6.77% |
Dec 31, 2023 | 111.90M | 3.60M | 3.32% |
Dec 31, 2022 | 108.30M | 7.41M | 7.35% |
Dec 31, 2021 | 100.89M | 14.44M | 16.70% |
Dec 31, 2020 | 86.45M | -17.25M | -16.64% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jardine Cycle & Carriage | 28.51B |
Genting Singapore | 2.53B |
The Hour Glass | 1.17B |
Hong Leong Asia | 4.25B |
ValueMax Group | 456.18M |
Stamford Land Corporation | 164.80M |
Banyan Tree Holdings | 380.64M |
Hotel Grand Central | 140.49M |